Saudi Minister of Economy and Planning Faisal Alibrahim, on behalf of Minister of Health Fahad AlJalajel, signed on Monday a memorandum of understanding (MoU) with the French Ministry of Health, Families, Autonomy and Persons with Disabilities on the sidelines of the visit of Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, to France.
The MoU aims to boost health cooperation between Saudi Arabia and France in several priority areas, most notably public health and health security, governance of health systems, quality of care, patient safety, preparedness and response to health emergencies, and development of the health workforce and capabilities.
It also covers digital health and artificial intelligence, research and development, innovation and clinical trials, supply chains and pharmaceutical industries, as well as investment and health partnerships.
The agreement builds on the longstanding relations between the two countries and seeks to strengthen the exchange of expertise and partnerships.
It supports research and innovation, the development of future health solutions and technologies, capability building and investment, the resilience of supply chains, health and pharmaceutical security, and the sustainability and quality of health services. These efforts support the objectives of the Health Sector Transformation Program under Saudi Vision 2030.
The Saudi National Institute of Health signed an MoU with French pharmaceutical company Sanofi on the sidelines of the Saudi-French Investment Forum in Paris.
The MoU aims to boost cooperation in research and development, innovation, and clinical research, and develop public-private partnerships to support the development of promising therapeutic solutions and health technologies, strengthen the health research and innovation ecosystem, and build research capabilities in line with the objectives of the Health Sector Transformation Program under Saudi Vision 2030.
The MoU builds on the longstanding relations between Saudi Arabia and France and reflects both sides' commitment to exchanging expertise and developing high-impact partnerships that support clinical research, advance innovation, and translate research outputs into innovative and sustainable healthcare solutions that serve human health.
